Eisai Epilepsy Medicine Wins U.S. Approval for Seizures

Eisai Co.’s epilepsy drug won U.S. approval to treat patients who suffer seizures as a result of the disease.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.